Enhabit said on 23 February it had agreed to be acquired by Kinderhook Industries in an all-cash deal at $13.80 a share, valuing the US home health and hospice provider at about $1.1bn including debt.
Why Kinderhook Industries is buying Enhabit, Inc.
Enhabit's chief executive Barb Jacobsmeyer said private ownership would provide resources for long-term investment in staff, clinical quality and innovation without the short-term pressures of public markets. Kinderhook said home-based care was a long-standing focus and that it would back management to expand access.
Deal terms and financing
The price represents a 24.4% premium to the 20 February close and 33.8% to the 60-day volume-weighted average. Certain executives signed voting and support agreements.
Regulatory approvals and timing
The deal required stockholder and regulatory approvals and was expected to close in the second quarter. Kinderhook completed it on 15 May 2026, paying shareholders about $762m, Home Health Care News reported.
Market context
Enhabit operates about 250 home health and 117 hospice locations across 34 to 35 states. Kinderhook, a middle-market firm founded in 2003, has invested in several home health platforms.
